ENDRA Life Sciences Inc. Quarterly Current Ratio in % from Q3 2017 to Q2 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ENDRA Life Sciences Inc. quarterly Current Ratio history and growth rate from Q3 2017 to Q2 2025.
  • ENDRA Life Sciences Inc. Current Ratio for the quarter ending June 30, 2025 was 485 %, a 57.1% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 485 +176 +57.1% Jun 30, 2025
Q1 2025 518 +221 +74.5% Mar 31, 2025
Q4 2024 411 +78.9 +23.8% Dec 31, 2024
Q3 2024 373 +45 +13.7% Sep 30, 2024
Q2 2024 309 -111 -26.5% Jun 30, 2024
Q1 2024 297 -251 -45.8% Mar 31, 2024
Q4 2023 332 -331 -49.9% Dec 31, 2023
Q3 2023 328 -462 -58.5% Sep 30, 2023
Q2 2023 420 -436 -50.9% Jun 30, 2023
Q1 2023 548 -319 -36.8% Mar 31, 2023
Q4 2022 663 -446 -40.2% Dec 31, 2022
Q3 2022 790 -365 -31.6% Sep 30, 2022
Q2 2022 856 -140 -14.1% Jun 30, 2022
Q1 2022 867 +101 +13.3% Mar 31, 2022
Q4 2021 1.11K +741 +202% Dec 31, 2021
Q3 2021 1.15K +878 +317% Sep 30, 2021
Q2 2021 996 +764 +330% Jun 30, 2021
Q1 2021 765 +528 +223% Mar 31, 2021
Q4 2020 368 +92.9 +33.8% Dec 31, 2020
Q3 2020 277 -65.8 -19.2% Sep 30, 2020
Q2 2020 232 -128 -35.7% Jun 30, 2020
Q1 2020 237 -180 -43.2% Mar 31, 2020
Q4 2019 275 -115 -29.5% Dec 31, 2019
Q3 2019 343 -30.5 -8.16% Sep 30, 2019
Q2 2019 360 -340 -48.6% Jun 30, 2019
Q1 2019 418 -693 -62.4% Mar 31, 2019
Q4 2018 390 -258 -39.8% Dec 31, 2018
Q3 2018 374 -32.3 -7.96% Sep 30, 2018
Q2 2018 700 Jun 30, 2018
Q1 2018 1.11K Mar 31, 2018
Q4 2017 648 Dec 31, 2017
Q3 2017 406 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.